Research area
Prostate Cancer biologic therapy trials
Every prostate cancer study listed here tests a biologic, such as a vaccine, an antibody, or a cell or gene therapy. Whether you are looking for yourself or for someone in your family, Cancer Biologic Trials can help you find out if a study may be a fit.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Prostate cancer biologic therapy studies in numbers
- prostate cancer biologic therapy studies recruiting in the U.S.
- 28
- states with a study site
- 38
- studies that accept healthy volunteers
- 2
Source: ClinicalTrials.gov. Data processed .
Find prostate cancer biologic therapy studies by state
These states have the most studies recruiting right now.
California
8 studies recruiting.
New York
8 studies recruiting.
South Carolina
6 studies recruiting.
Texas
6 studies recruiting.
Florida
5 studies recruiting.
Maryland
5 studies recruiting.
Prostate cancer biologic therapy studies recruiting now
As of November 18, 2026, 28 prostate cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.
What they test
- biologics such as vaccines or antibodies23
- medications10
- procedures6
- genetic approaches5
- other approaches5
A study can test more than one.
Main purpose
- treating a condition22
- basic science1
- diagnosis1
- other purposes1
Phase
- Early Phase 11
- Phase 113
- Phase 1/22
- Phase 28
- Phase 31
- No phase1
- Observational2
Studies of devices and behavioral approaches have no phase.
Who runs them
- industry14
- university, hospital or other11
- government3
Who they enroll
- adults (18 to 64)28
- older adults (65 and over)28
2 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 28 studies.
Recently updated prostate cancer biologic therapy studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Allentown, PA · Ames, IA · Anaconda, MT · and 170 more U.S. locations
- Registry record
- NCT03866382 · updated
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
- Phase 2
- Ages 18 to 120
- Male participants
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT07574541 · updated
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
- No phase
- Ages 55 to 69
- Male participants
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Boston, MA
- Registry record
- NCT05926102 · updated
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- City of Hope Medical Center
- Recruiting in
- Duarte, CA
- Registry record
- NCT05805371 · updated
JUR-003 in Adult Patients With Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Juri Biosciences, Inc.
- Recruiting in
- Grand Rapids, MI · Lake Success, NY · Nashville, TN · and 1 more U.S. location
- Registry record
- NCT07824349 · updated
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Ann Arbor, MI · Aurora, CO · Bala-Cynwyd, PA · and 42 more U.S. locations
- Registry record
- NCT07164443 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What prostate cancer biologic therapy studies look at
The prostate cancer studies on this site all test a biologic: a vaccine, an antibody, or a cell or gene therapy, for example. Each one is set up around one particular question. Because of that, the visits and tasks involved for you, or for the person you are helping, will not match those of another study.
The biologic under study is investigational in every case. How well it does its job and which risks come with it are things researchers have yet to pin down, and the study exists to find out.
Who may be able to take part
Requirements for a prostate cancer biologic study belong to that study alone. Your age may count. So may your medical background, any medicines you are on at present, and the way the condition affects you. People without the condition are enrolled in some studies too.
Nobody expects you, or a relative reading on your behalf, to figure out eligibility alone. A screening visit is where the study team looks into it. Our guide explains how screening and eligibility are handled.
What taking part usually involves
A first conversation
You start by talking with a coordinator, who gives a broad outline of the study and takes whatever questions you or your family bring. This conversation comes first, ahead of every other step.
Informed consent
Next comes a written document from the study team. It lays out everything about the study, the known risks included, and whether to agree is up to you.
Screening
The study team asks you health questions and arranges tests, and the results tell them if this prostate cancer biologic study suits you. Some people who go through this step do not end up joining.
Study visits
Joining means a set schedule of visits, which is how the team keeps track of your health along the way. Stopping is always allowed. You may withdraw from the study whenever you choose.
Questions about prostate cancer biologic therapy studies
Do I need a diagnosis to join a study about prostate cancer?
That varies from one prostate cancer biologic study to the next. A confirmed diagnosis is needed for some. Others assess you, or the person you're reading for, during screening, and the study team will explain which applies.
Would I have to change the care I receive now?
Nothing about your care should be changed by you alone. Whether your present care carries on depends on the study: some permit it, some do not. This is something the study doctor will review with you, and you are welcome to discuss it with your regular doctor before making a decision.
Is there a cost to take part?
In general, the study medication, the tests done for the study, and the study visits come at no cost to the people taking part. Our page on costs has the details.
Ask about prostate cancer biologic therapy studies
Send a few details and a coordinator will contact you about prostate cancer biologic studies. Asking does not sign you or your family member up for anything.
Independent information
- Prostate Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)